Exploring the Impact of Gut Microbiota in COVID-19 Immune Resilience

Soumya Kanta Hati

Abstract

Gut microbiota—the community of microorganisms that live in the human gastrointestinal tract—has found to play a significant role in the immune system and overall health of individuals. Recent studies have indicated a possible link of gut microbiota with COVID-19, the respiratory illness caused by the SARS-CoV-2 virus. Studies have shown that individuals with COVID-19 often experience gastrointestinal symptoms such as diarrhea, nausea, and vomiting, indicating that the virus may also impact the gut microbiota. Additionally, changes in the composition and diversity of the gut microbiota are found in COVID-19 patients, especially those with severe cases. It has been claimed that a good and balanced gut microbiota can fight against COVID-19 by boosting immune function and decreasing inflammation. However, the precise processes through which gut microbiota might alter COVID-19 outcomes are still under investigation. Interventions targeting gut microbiota, such as probiotics or prebiotics, have also been suggested as potential therapeutic options for COVID-19. Nevertheless, further studies are required to completely understand the association of gut microbiota with COVID-19 and in addition to establish the effectiveness of such interventions. Understanding the involvement of gut microbiota with COVID-19 has crucial implications for disease prevention and therapy.

Abstract

Keywords